Literature DB >> 11579886

Acute lower respiratory infections among children hospitalized in Bangui, Central African Republic: toward a new case-management algorithm.

J Pépin1, A M Demers, F Mberyo-Yaah, S Jaffar, C Blais, P Somsé, G Bobossi, P Morency.   

Abstract

To measure the performance of the current WHO algorithm in identifying children at higher risk of death, children aged 2-59 months who presented with cough and/or difficult breathing and were admitted into the paediatric hospital of Bangui (Central African Republic) during a 1-year period (1996/97) were investigated. Among children with subcostal indrawing, mortality and severity of oxygen desaturation were identical whether or not they also had tachypnoea. Among children with a 'severe pneumonia', those who also fulfilled the 'very severe disease' definition had a higher risk of death (31/132, 23.5%) than those who did not (12/106, 11.3%, P = 0.02). However, this 'very severe disease' definition did not predict death when used in children who did not have severe pneumonia. To identify variables that would better predict death, combinations of symptoms and signs were examined among the subgroup of children with indrawing. Nine combinations had both a sensitivity and specificity over 60%. 'Grunting and/or nasal flaring' had a sensitivity of 72% and a specificity of 66% in predicting death, and might be easier to use by primary health care personnel than other combinations. A new algorithm is proposed for the management of children aged 2-59 months presenting with cough and/or difficult breathing. The definition of pneumonia would be unchanged (tachypnoea). Severe pneumonia would remain defined on indrawing regardless of respiratory rate, except that indrawing should be lower chest wall and/or intercostal. In health facilities where intravenous antibiotics, chloramphenicol and/or oxygen are available, entry into a 'very severe pneumonia' category would be based on 'grunting and/or nasal flaring' among children with indrawing. In our study population, the mortality rates in the categories based on these definitions were 0.8% (1/127) in children with no pneumonia, 0.9% (1/116) in children with pneumonia, 7.7% (12/156) in children with severe pneumonia and 31.1% (33/106) in children with very severe pneumonia.

Entities:  

Mesh:

Year:  2001        PMID: 11579886     DOI: 10.1016/s0035-9203(01)90199-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Outpatient treatment of children with severe pneumonia with oral amoxicillin in four countries: the MASS study.

Authors:  Emmanuel Addo-Yobo; Dang D Anh; Hesham F El-Sayed; LeAnne M Fox; Matthew P Fox; William MacLeod; Samir Saha; Tran A Tuan; Donald M Thea; Shamim Qazi
Journal:  Trop Med Int Health       Date:  2011-05-04       Impact factor: 2.622

2.  Hepatocyte growth factor can guide treatment of Mycoplasma pneumoniae pneumonia in children.

Authors:  Lun Qin Liu; Zhi Hua Wang; Hai Yun Yao
Journal:  Exp Ther Med       Date:  2020-03-12       Impact factor: 2.447

3.  Case management of childhood pneumonia in developing countries.

Authors:  Philip Ayieko; Mike English
Journal:  Pediatr Infect Dis J       Date:  2007-05       Impact factor: 2.129

Review 4.  Challenges to improving case management of childhood pneumonia at health facilities in resource-limited settings.

Authors:  Stephen M Graham; Mike English; Tabish Hazir; Penny Enarson; Trevor Duke
Journal:  Bull World Health Organ       Date:  2008-05       Impact factor: 9.408

5.  Low rates of treatment failure in children aged 2-59 months treated for severe pneumonia: a multisite pooled analysis.

Authors:  Matthew P Fox; Donald M Thea; Salim Sadruddin; Abdul Bari; Rachael Bonawitz; Tabish Hazir; Yasir Bin Nisar; Shamim A Qazi
Journal:  Clin Infect Dis       Date:  2012-12-21       Impact factor: 9.079

6.  Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).

Authors:  Rai Asghar; Salem Banajeh; Josefina Egas; Patricia Hibberd; Imran Iqbal; Mary Katep-Bwalya; Zafarullah Kundi; Paul Law; William MacLeod; Irene Maulen-Radovan; Greta Mino; Samir Saha; Fernando Sempertegui; Jonathon Simon; Mathuram Santosham; Sunit Singhi; Donald M Thea; Shamim Qazi
Journal:  BMJ       Date:  2008-01-08

Review 7.  The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health study.

Authors:  J Anthony G Scott; Chizoba Wonodi; Jennifer C Moïsi; Maria Deloria-Knoll; Andrea N DeLuca; Ruth A Karron; Niranjan Bhat; David R Murdoch; Jane Crawley; Orin S Levine; Katherine L O'Brien; Daniel R Feikin
Journal:  Clin Infect Dis       Date:  2012-04       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.